Exploratory Research and Hypothesis in Medicine (ERHM) publishes original exploratory research articles and state-of-the-art reviews that focus on novel findings and the most recent scientific advances that support new hypotheses in medicine, with an emphasis on epidemiology, infectious diseases, cancers, cardiovascular diseases, artificial intelligence, and machine learning.

The journal accepts a wide range of topics, including innovative diagnostic and therapeutic modalities as well as insightful theories related to the practice of medicine. The exploratory research published in ERHM does not necessarily need to be comprehensive and conclusive, but the study design must be solid, the methodologies must be reliable, the results must be true, and the hypothesis must be rational and justifiable with evidence.

ERHM welcomes and encourages article submission of original exploratory research as well as novel and timely state-of-the-art full reviews, mini-reviews, and opinion articles from leading scientists and scholars around the world.

Topics of particular interest include but are not limited to:

• New methods and concepts in the diagnosis, treatment, or prevention of disease
• Novel discoveries in all diseases and disease mechanisms
• Risk and prognostic factors of diseases
• Changes in clinical paradigms and treatment approaches
• Cutting edge technologies that can help improve scientific understanding
• Preliminary findings that may change current thinking in a particular field

Exploratory Research and Hypothesis in Medicine (ERHM) adopts open access publishing model, and all articles are distributed under the terms of the CC BY-NC 4.0 license (http://creativecommons.org/licenses/by-nc/4.0/). Under this license, anyone may copy, distribute, or reuse these articles for non-commercial purposes, provided the original work is properly cited. Manuscripts submitted for publication in an open access journal are subject to the same rigorous peer-review and quality control as in scholarly subscription journals.

ERHM recognizes the distinct advantages of using an open access publication model to timely disseminate innovative and important research findings. Unrestricted free access to our publications is anticipated to foster intellectual discourse across geographic and disciplinary boundaries. To support the success of our open access approach, we ensure the integrity and high quality of research published in our journal by practicing a rigorous peer review process and by following strict guidelines for ethics in publication and in conduct of the scientific process.

All manuscripts submitted to ERHM must meet the following criteria for publication:

• Topics with timely relevance to the general field or specialties in basic and clinical medicine;
• A must-have section of “hypothesis/ future direction/ prospect/ prediction” included for all research and review articles;
• Results and findings that have not been previously published elsewhere;
• Research performed with adherence to accepted global standards for ethics in the scientific process;
• Ethical reporting of data to protect the rights and privacy of study participants;
• Appropriate statistical analyses, with sufficient descriptions of all statistical methods used;
• Conclusions supported by the data presented;
• All funding sources and their roles cited;
• For clinical trials, the registration number cited;
• Manuscript written in standard American (US) English and formatted according to the journal-specific guidelines;
• No instances of textual plagiarism, including ‘text recycling/self-plagiarism”.

ERHM currently publishes 4 issues a year, in March, June, September and December.

ERHM Metrics (2023)
Acceptance rate: 26.6% 
Median time from submission to first decision: 21.5 days 
Median time from acceptance to online publishing: 30 days

ERHM adopts the open access publishing model. Revenues are generated from article processing charges, permission fees, and reprints.

ERHM is owned and published by Xia & He Publishing Inc.